NeuroOne Medical Technologies Corporation— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$9M
↑+32.1% +$2Mvs FY2024
Total Liabilities
$2M
↓-38.9% -$1Mvs FY2024
Equity
$6M
↑+118.1% +$3Mvs FY2024
Cash
$4M
↑+214.0% +$2Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $9M | $6M |
| Current Assets | $8M | $6M |
| Cash | $4M | $1M |
| ST Investments | $0 | $0 |
| Receivables | $3M | $2M |
| Inventory | $2M | $2M |
| Other Current | $177K | $278K |
| Non-Current Assets | $511K | $783K |
| PPE | $245K | $382K |
| Goodwill | $0 | $0 |
| Intangibles | $39K | $62K |
| Investments | $0 | $0 |
| Other Non-Current | $226K | $339K |
| Total Liab+Eq | $9M | $6M |
| Current Liab. | $1M | $2M |
| Accounts Payable | $552K | $745K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $706K | $826K |
| Non-Current Liab. | $917K | $2M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $917K | $2M |
| Equity | $6M | $3M |
| Retained Earnings | $80M | $73M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · NMTC · Comparing FY2025 vs FY2024